- 阅读权限
- 20
- 精华
- 最后登录
- 1970-1-1
- 在线时间
- 小时
- 主题
- 好友
- 相册
- 分享
- 日志
- 记录
- UID
- 1288468
- 帖子
- 0
该用户从未签到
|

楼主 |
发表于 2020-2-11 11:32
|
显示全部楼层
**** 作者被禁止或删除 内容自动屏蔽 ****
两位兄弟,不用争执了,你们提到的这个药物治疗“埃博拉病毒”无效,对于新冠肺炎的治疗效果尚没有确定,目前仅仅是临床试验阶段。给你们贴两个证据:
1、Since the outbreaks of SARS and the often fatal Ebola virus, U.S. federal money for developing drugs and vaccines for emerging diseases has increased, and drugs that may combat coronaviruses are ready for trials. One is remdesivir, a treatment from Gilead Sciences Inc. that failed tests in people with Ebola. The first U.S. coronavirus patient, in Washington state, received the drug after his condition worsened. He improved the day after he was infused, according to results reported in the New England Journal of Medicine. Gilead says it s shipped enough of the drug to China to treat 500 patients and is working to produce more if the trials starting imminently in China are promising. We have an army of people working 24/7 now opening up manufacturing lines and doing whatever we can to get as much available as quickly as possible, says Chief Medical Officer Merdad Parsey. Yet the drug may already be the focus of an intellectual-property dispute: China s Wuhan Institute of Virology has applied for a patent on its use against the coronavirus.
这个是“彭博商业周刊-2020-02-10”中第10页的内容;
2、Ajab in the dark The issues surrounding any potential vaccine make questions about medicines to treat those who have become gravely ill particularly acute. Licensed medicines to treat coronaviruses do not currently exist, but experimental drugs are in development, with some early data on their use. One that has been highlighted as promising is called remdesivir, which is made by Gilead, a drug firm. Two randomised controlled trials will start enrolling patients in mid-February. Remdesivir was developed to treat Ebola but in laboratory tests has been shown to be effective against a range of viruses. A combination of two drugs usually used in hiv treatment also looks promising and is already being tried on patients, says Vasee Moorthy who helps set research and development priorities at the whoduring epidemics.
这个是“经济学人 2020-02-08”中第56页的内容;
方便的话,可以把原文看一下
一句话:Remdesivir这个药物有没有用,无法确定!!!!
|
|